The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martin, D. L.
Right arrow Articles by Heinzel, F. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, D. L.
Right arrow Articles by Heinzel, F. P.
The Journal of Immunology, 2000, 164: 779-785.
Copyright © 2000 by The American Association of Immunologists

IFN-{gamma} Is Necessary But Not Sufficient for Anti-CD40 Antibody-Mediated Inhibition of the Th2 Response to Schistosoma mansoni Eggs1

Diana L. Martin*, Christopher L. King*,{dagger}, Eric Pearlman*, Ellen Strine* and Frederick P. Heinzel2,*,{dagger}

* Department of Pathology and Division of Geographic Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106; and {dagger} Research Service, Veterans Affairs Medical Center, Cleveland OH 44106


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The injection of Schistosoma mansoni eggs into the footpads of mice results in a localized Th2 cytokine response and tissue eosinophilia. We examined whether treatment with CD40-activating Abs would block the development of Th2 cytokine responses and eosinophilic tissue pathology in this model. Seven days after C57BL/6 mice were injected with eggs and the FGK45 anti-CD40 Ab, Ag-specific synthesis of IL-4, IL-5, and IL-13 in lymph node culture was reduced (>10-fold) relative to control mice treated with eggs and rat IgG. In contrast, IFN-{gamma} and IL-12 were increased in both culture supernatants and in the serum. Similar changes in lymph node cytokine mRNA were observed in vivo, and tissue eosinophilia was reduced nearly 20-fold. Th2 cytokine responses in anti-CD40-treated IFN-{gamma}-/- and IL-12 p40-/- C57BL/6 mice were unaffected, although anti-CD40 induced high levels of systemic and local IFN-{gamma} production in both wild-type and IL-12 p40-/- mice. We conclude that CD40-activating treatments strongly reverse the immune phenotype generated in response to a classic, Th2-biasing stimulus and stimulate IFN-{gamma} through a novel IL-12-independent pathway. This model for Th1-deviating immune therapy may have relevance to the treatment of Th2-dependent diseases in general.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Chronic infection with Schistosoma mansoni results in granulomatous disease that may eventually lead to fibrosis, occlusion of the presinusoidal vascular bed, and fatal portal hypertension. Granulomas form around viable eggs trapped in the small vessels of the liver and intestine of their mammalian host. Granuloma development follows the appearance of Th2-dominant immune responses characterized by high levels of IL-4, IL-5, and IL-13 production (1). There is increasing evidence that Th2 cytokines are necessary for granuloma development and that immune deviation of the egg-induced immune response toward a Th1-polarized phenotype attenuates disease. Specifically, vaccination of mice with rIL-12 and eggs prevented the subsequent development of liver pathology during murine schistosomiasis by IFN-{gamma}-dependent mechanisms (2, 3, 4). Consequently, the characterization of other immune interventions capable of abrogating S. mansoni egg-induced Th2 development may indicate potential therapeutic approaches while providing mechanistic insights into this important disease.

Because egg laying is delayed by several weeks in the mouse model of natural infection, the early immunologic events associated with Th2 cell differentiation to egg Ags are examined more conveniently by injecting S. mansoni eggs into the footpads of mice (5). This reproducibly triggers Ag-specific Th2 responses within the popliteal lymph node that peak within 1 wk of injection and that can be modulated by simultaneous administration of recombinant cytokines or neutralizing mAbs specific for cytokines or costimulatory molecules (6, 7). This model is therefore well suited for the analysis of the early events associated with induction and regulation of Th2 subset differentiation, as well as for examining potential therapeutic interventions. For example, administration of rIL-12 decreased egg Ag-induced IL-4 and IL-5 production (6), consistent with the well-characterized Th1-polarizing effects of IL-12 in models of cellular immunity (8). In the following studies, we test whether Ab-mediated activation of CD40 on accessory cells at the time of egg injection would similarly redirect the emerging immune response away from the Th2 cytokine phenotype normally induced in this model.

Although CD40 was originally described as a receptor protein on B cells that activates B cell growth and differentiation in support of Ab production (9), the engagement of macrophage and dendritic cell CD40 with the CD154 counterligand on T cells induces a coordinated set of responses important in T cell differentiation. These include the production of immunoregulatory cytokines, such as IL-12, and the up-regulation of costimulatory proteins and Ag-presenting capability (10, 11, 12). The complexity of these responses suggests that experimental activation of CD40 by agonistic Abs or soluble CD154 may affect T cell differentiation by mechanisms that extend beyond those mediated by IL-12 alone. The immunoregulatory properties of in vivo CD40 activation have been demonstrated by the Th1-promoting effects of anti-CD40 mAb during murine leishmaniasis in Th2-predisposed, susceptible BALB/c mice and in the disruption of experimentally induced Th2-dependent neonatal transplantation tolerance to alloantigen (13, 14). Similarly, mice treated with DNA encoding the soluble CD40L trimer become highly resistant to tumor metastasis and to Leishmania major infection (15).

On the basis of these studies, we hypothesized that experimental activation of CD40 at the time of S. mansoni egg injection would switch the developing Ag-specific immune response from a Th2 to a Th1 cytokine phenotype. To test this hypothesis, eggs were injected into the footpad of mice concurrent with administration of agonistic anti-CD40 mAb FGK45, which activates CD40 in vitro in a manner similar to that observed with the natural ligand CD154 (16, 17, 18). In this well-characterized model for Th2 CD4+ T cell development, anti-CD40 treatment strongly suppressed the development of IL-4-, IL-5-, and IL-13-secreting immune responses and instead promoted the development of CD4+ T cell-dependent IFN-{gamma} synthesis in vivo. In parallel experiments using IFN-{gamma} and IL-12 (p40) knockout mice, anti-CD40 was unable to suppress IL-4, IL-5, and IL-13 production in response to S. mansoni egg Ags, despite the presence of strong, anti-CD40-inducible IFN-{gamma} responses in IL-12 knockout mice.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Mice

Six- to 8-wk-old C57BL/6J and IL-12 p40-/- (C57BL/6J IL-12btm/Jm) (19) mice were obtained from The Jackson Laboratory (Bar Harbor, ME). Six- to 8-wk-old IFN-{gamma}-deficient mice, C57BL/6 IFN-{gamma}tm/tls (20), were originally obtained from Genentech (South San Francisco, CA) and bred locally. All mice were housed in microisolator cages at Case Western Reserve University in the animal resource center.

In vivo activation of CD40

Six- to 8-wk-old female C57BL/6J, IFN-{gamma}-/-, or IL-12 p40-/- mice were injected i.p. with 250 µg of an activating CD40 mAb or with a control rat IgG (Sigma, St. Louis, MO), followed by inoculation with 5000 S. mansoni eggs in each hind footpad, as described (7). Mice were sacrificed on day 7 by cervical dislocation. FGK45 and soluble recombinant CD40 ligand have similar in vitro abilities to stimulate IL-12 p40 production from cultured LNC3 (16), and FGK45 stimulates CD40 in vivo (17).

Culture of LNC

Mice were bled and sacrificed 7 days after egg injection. Single cell suspensions of popliteal LNC were made by forcing the lymph nodes through a mesh screen. The cells were washed extensively, then cultured at 5 x 106/ml in DMEM (BioWhittaker, Walkersville, MD) containing 10% FBS (HyClone, Logan, UT), 2 mM glutamine (BioWhittaker), 10 mM HEPES (Sigma), 2-ME (Life Technologies, Grand Island, NY), and antibiotics (BioWhittaker) in 96-well tissue culture plates (Corning, Corning, NY). The cells were incubated with 10 µg/ml {alpha}IL-4R mAb (Genzyme, Cambridge, MA) to prevent sequestration of IL-4 (21), along with medium alone or 25 µg/ml soluble egg Ag, prepared as previously described (22), in a 37°C incubator with 5% CO2. Culture supernatants were removed 72 h later for analysis of cytokine content by ELISA. Remaining cells from LNC preparations were resuspended in STAT60 (TelTest B, Friendswood, TX) and frozen at -70°C for later RNA extraction.

RT-PCR and Southern blotting

RNA was extracted from STAT60 tissue homogenates with chloroform, precipitated with isopropanol, and rinsed with ethanol, as per manufacturer’s protocol. cDNA was made, and cytokine-specific DNA products were amplified using Taq polymerase, as previously described (7). The PCR product was transferred to positively charged nylon membranes (Boehringer Mannheim, Indianapolis, IN), prehybridized, then probed with digoxigenin-labeled cytokine-specific oligonucleotides. After incubating with antidigoxigenin-conjugated alkaline phosphatase, the blots were developed with Lumi-Phos (Boehringer Mannheim) and exposed to Kodak Biomax MR film (Eastman Kodak, Rochester, NY). Thirty-minute exposures are shown for all blots.

Enzyme-linked immunosorbent assay (ELISA)

Cytokine levels in culture supernatants and in serum were determined by two-site ELISA, as previously described (7). IL-13 levels were determined using the Quantikine kit (R&D Systems, Minneapolis, MN). IL-12 p40 and p70 levels were measured by ELISA, using previously reported reagents and techniques (23). Concentrations were calculated using recombinant cytokines as standards.

Immunomagnetic selection of CD4+ cells for RNA and enzyme-linked immunospot analysis

CD4+ cells were selected with immunomagnetic beads coated with anti-CD4, according to the manufacturer’s instructions (Miltenyi Biotec, Auburn, CA). Total LNC, CD4+ LNC, and CD4- LNC populations were collected, and RNA obtained by phenol/chloroform extraction. RT-PCR analysis of HPRT and IFN-{gamma} levels was performed. Densitometry data were obtained using the ScanAnalysis program (Biosoft, Ferguson, MO). Frequencies of IFN-{gamma}-secreting cells from total LNC and CD4-depleted LNC of anti-CD40-treated mice were determined by enzyme-linked immunospot, as previously described (7).

Histology

Eosinophils were detected according to the method described by Pearlman et al. (24, 25). Briefly, footpads were fixed in 10% Formalin for 24 h and processed in a Tissue-Tek VIP tissue processor. Five-micrometer sections were immunostained with rabbit antisera to murine eosinophil MBP 18 kindly provided by Drs. Kirsten Larson and Jamie Lee at the Mayo Clinic (Scottsdale, AZ). Sections were incubated at room temperature in a humid chamber for 2 h with {alpha}MBP (diluted 1/5000) in 0.05 M TBS (pH 7.6) containing 1% FCS. After washing, sections were incubated for 30 min with biotinylated goat anti-rabbit Ig (Dako, Carpenteria, CA) diluted 1/200 or prediluted Rat Link (BioGenex, San Ramon, CA), washed, and incubated with prediluted alkaline phosphatase-conjugated streptavidin (BioGenex). Positive reactivity was detected using Vector Red Substrate containing 12 mg levamisole (Sigma), followed by counterstaining with modified Harris’ hematoxylin (Richard-Allen, Kalamazoo, MI).

Statistical analysis

Cytokine values from experimental vs control groups were compared using a Student’s t test, with p < 0.05 being considered statistically significant.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Anti-CD40 treatment decreases IL-4, IL-5, and IL-13 production in response to S. mansoni eggs

To test whether anti-CD40 decreases the Th2 response to S. mansoni eggs, we injected anti-CD40 i.p. into C57BL/6J mice at the same time they were inoculated in the footpad with 5000 eggs. Mice were sacrificed 7 days later, and cytokine levels were measured in cultures of popliteal LNC and in the serum. LNC of mice injected with eggs alone generated abundant IL-4, IL-5, and IL-13 in response to egg Ag. With the exception of IL-13, these cytokines were also secreted spontaneously. In contrast, mice treated with anti-CD40 mAb at the time of egg inoculation were unable to generate detectable levels of either spontaneous or Ag-inducible IL-4, IL-5, and IL-13 in culture (Fig. 1GoA). Conversely, the production of IFN-{gamma}, which was undetectable in egg-injected control mice, increased dramatically in anti-CD40-treated mice (Fig. 1GoA). IL-12 p40 levels were also increased more than 5-fold by prior CD40 activation. Anti-CD40-treated mice similarly demonstrated increased levels of IL-12 p40, IL-12 p70, and IFN-{gamma} in the serum on day 7 (Fig. 1GoB).



View larger version (19K):
[in this window]
[in a new window]
  		FIGURE 1. Treatment with anti-CD40 mAb alters the cytokine response to S. mansoni eggs. A, Draining LN were harvested 7 days after s.c. inoculation with eggs with either 250 µg of rat IgG or rat anti-CD40 IgG given by i.p. injection. Culture conditions included medium alone or medium containing soluble egg Ag (SEA). Bars represent the mean ± SEM of cytokine concentrations determined for groups of three mice (each mouse tested in duplicate) and are representative of 10 experiments. Levels of IL-4, IL-5, and IL-13 produced in cultures of naive C57BL/6 mice (not shown) did not exceed 60 pg/ml. IFN-{gamma}, and IL-12 p40 levels in naive lymph node culture were ~240 and 400 pg/ml, respectively. B, Mice were bled at the time of sacrifice, and serum levels of IFN-{gamma}, IL-12 subunit p40, and IL-12 heterodimer p70 were measured using a two-site ELISA. Bars represent means ± SEM of duplicate wells for three mice per group and are representative of three experiments. All anti-CD40-induced changes in cytokine levels compared with rat IgG were statistically significant (p < 0.001).

 
To determine whether these anti-CD40-dependent effects on Th2 and Th1 cytokine production were present in vivo, we examined steady state levels of cytokine mRNA present in the lymph node at 7 days using comparative RT-PCR analysis. As shown in Fig. 2Go, anti-CD40-treated mice expressed markedly reduced levels of IL-4 mRNA and reciprocally increased levels of IFN-{gamma} mRNA. These data demonstrate that anti-CD40 differentially regulates the development of in vivo Th2 and Th1 cytokine responses to S. mansoni egg injection. Although inhibitory effects on IL-4-producing responses had been described in other models (13, 14, 15), the current findings extend the regulatory effects of anti-CD40 to the inhibition of IL-5 and IL-13 synthesis.



View larger version (91K):
[in this window]
[in a new window]
  		FIGURE 2. Anti-CD40 mAb treatment suppresses lymph node IL-4 mRNA expression while enhancing IFN-{gamma} mRNA expression. Mice were treated with eggs and, as indicated, rat IgG or anti-CD40 mAb. LNC were obtained on day 7, pooled, and RNA extracted using phenol/chloroform (STAT60). Levels of cytokine-specific transcript were evaluated by RT-PCR. Data are Southern blot analyses of PCR products and are representative of three experiments. Levels of the housekeeping gene HPRT are included to control for relative amounts of different RNA sample incorporated into cDNA.

 
Anti-CD40 treatment decreases footpad eosinophilia

To determine whether anti-CD40-induced cytokine modulation was associated with changes in the eosinophilic predominance of the subdermal cellular response elicited by S. mansoni eggs, we immunostained paraffin-embedded footpad sections with Abs specific for the eosinophil granule protein, MBP. Treatment of mice with anti-CD40 markedly decreased the extent of tissue eosinophilia at the site of egg injection compared with control mice (Fig. 3Go). The average number of eosinophils per high power field decreased from 124 ± 19 in control mice to 4.56 ± 0.62 in mice treated with anti-CD40 (p = 0.003). These findings are consistent with the generalized inhibition of Th2 activities resulting from anti-CD40 treatment, including suppressed synthesis of the eosinophil growth factor IL-5 (26).



View larger version (54K):
[in this window]
[in a new window]
  		FIGURE 3. Treatment with anti-CD40 decreases footpad eosinophilia. Mice were treated as described in Fig. 1Go. On day 7, footpads were removed and embedded in paraffin. Five-micrometer sections were stained with {alpha}MBP, and positive reactivity was detected using Vector Red Substrate containing 12 mg levamisole, followed by counterstaining with modified Harris’ hematoxylin. Representative sections were photographed at x40 magnification. The average number of eosinophils per high power field (x120) was 124 ± 19 for control mice and 4.56 ± 0.62 for anti-CD40-treated mice. These values represent the average ± SEM of eosinophils counted in three fields per mouse (n = 3).

 
IFN-{gamma} is necessary for the anti-CD40-induced suppression of the Th2 cytokine response

The role of IFN-{gamma} in the anti-CD40-induced down-regulation of S. mansoni egg-induced Th2 response was examined in C57BL/6 IFN-{gamma}-/- mice. Compared with the strong suppression of Th2 cytokine responses present 7 days after anti-CD40 treatment of egg-injected wild-type C57BL/6 mice, Ag-induced IL-4 and IL-5 levels were unaffected by anti-CD40 in IFN-{gamma}-/- mice (Fig. 4GoA). Although treatment of IFN-{gamma}-/- mice with anti-CD40 induced spontaneous IL-12 p40 production from cultured popliteal LNC (Fig. 4GoA), the addition of egg Ag repeatedly suppressed IL-12 p40 production in lymph node cultures from both IFN-{gamma}-/- and wild-type mice previously treated with anti-CD40. The serum of IFN-{gamma}-/- mice showed small, but significant increases in circulating IL-12 p40 following anti-CD40 treatment that was 3- to 4-fold reduced relative to anti-CD40-treated wild-type mice (Fig. 4GoB). These data show that the presence of IFN-{gamma} is necessary for anti-CD40-induced Th2 cytokine inhibition and critical for the optimal synthesis of IL-12 p40 in response to CD40 stimulation.



View larger version (14K):
[in this window]
[in a new window]
  		FIGURE 4. IFN-{gamma}-/- mice fail to down-regulate Th2 cytokine production in response to anti-CD40 mAb. A, C57BL/6 or IFN-{gamma}-/- mice were treated and LNC harvested on day 7, as described in Fig. 1Go. Data from wild-type or knockout IFN-{gamma} genotypes are designated along the abscissa as +/+ and -/-, respectively. Bars represent means ± SEM cytokine concentration in ng/ml determined by duplicate assay of four mice per group. Findings are representative of three experiments. B, C57BL/6 and IFN-{gamma}-/- mice were injected as described in Fig. 1Go and bled on day 7. Levels of IL-12 p40 in the serum at 7 days were determined by two-site ELISA. Bars represent means ± SEM for four mice per group. Data are representative of three experiments.

 
IL-12-deficient mice produce IFN-{gamma}, but fail to down-regulate S. mansoni egg-induced Th2 responses

We next examined whether IL-12 mediates anti-CD40-induced suppression of egg Ag-specific Th2 responses using C57BL/6 mice with a targeted mutation of the IL-12 p40 subunit gene. These mice are consequently unable to produce bioactive IL-12 p35/p40 heterodimer. Compared with inoculation with eggs alone, the administration of anti-CD40 in IL-12-/- mice failed to suppress IL-4 and IL-5 production (Fig. 5GoA). However, treatment with anti-CD40 induced levels of IFN-{gamma} in IL-12-/- mice that were comparable with those observed in wild-type mice (Fig. 5GoB). These results indicate that IFN-{gamma} in the absence of IL-12 is incapable of mediating anti-CD40-induced suppression of Th2 production.



View larger version (15K):
[in this window]
[in a new window]
  		FIGURE 5. Anti-CD40 induces IFN-{gamma} production, but does not decrease IL-4 or IL-5 production in IL-12 p40-/- mice. A, C57BL/6J IL-12 p40+/+ or p40-/- mice were treated and LNC harvested on day 7, as described in Fig. 1Go. Data from wild-type or knockout IL-12 p40 genotypes are designated along the abscissa as +/+ and -/-, respectively. Bars represent means ± SEM cytokine concentration in ng/ml determined by duplicate assay of five mice per group. Findings are representative of three experiments. B, C57BL/6 and IL-12 p40-/- mice were injected as described in Fig. 1Go and bled on day 7. Levels of IFN-{gamma} in the serum at 7 days were determined by two-site ELISA. Bars represent means ± SEM for five mice per group. Data are representative of three experiments.

 
To determine the cellular source of anti-CD40-induced IFN-{gamma}, we positively selected CD4+ cells from anti-CD40-treated wild-type and IL-12-/- mice and examined IFN-{gamma} mRNA levels. Densitometry analysis of RT-PCR data showed expression of IFN-{gamma} mRNA in the CD4+-enriched population of LNC from anti-CD40-treated C57BL/6 mice, while IFN-{gamma} mRNA expression was decreased 3-fold in the CD4-depleted population (Fig. 6Go). Furthermore, depletion of CD4+ cells from LNC of anti-CD40-treated mice resulted in a 90% decrease in the frequency of IFN-{gamma}-secreting cells (360 ± 28 vs 15 ± 8.6, data not shown). Similarly, CD4+ cells were the primary source of IFN-{gamma} production by LNC of anti-CD40-treated IL-12-/- mice. Depletion of CD4+ cells decreased IFN-{gamma} message levels by 10-fold (Fig. 6Go). These data show that anti-CD40 promotes the development of CD4+ cells producing IFN-{gamma} in the absence of endogenous IL-12.



View larger version (14K):
[in this window]
[in a new window]
  		FIGURE 6. CD4+ T cells from C57BL/6 and IL-12 p40-/- mice produce IFN-{gamma} in response to anti-CD40 treatment. Mice were treated as described in Fig. 5Go. LNC of anti-CD40-treated C57BL/6 or IL-12 p40-/- mice were pooled and subjected to selection with anti-CD4-coated immunomagnetic beads. Presort data represent unselected LNC, CD4+ represents positively selected LNC, and CD4- represents LNC unbound to anti-CD4-conjugated beads. Data show ratios of IFN-{gamma} to HPRT densitometry units and are representative of two experiments.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
The central finding of these studies is that anti-CD40 treatment blocks the ability of draining LNC to produce IL-4, IL-5, and IL-13 following footpad injection with S. mansoni eggs. Previous studies in mouse models of L. major infection and transplantation tolerance also demonstrated CD40-induced suppression of IL-4 production (13, 14). The wider range of Th2-associated cytokines affected by anti-CD40 in our studies indicates a generalized disruption of Th2 immune differentiation and not the selective suppression of individual cytokine responses. This is notable given the mutual independence of IL-4, IL-13, and IL-5 development and function in the setting of several well-defined Th2 immunopathologies. For instance, IL-13 and IL-4 are separately capable of inducing pulmonary granuloma formation around S. mansoni eggs (27), and both cytokines are critical in the induction of experimental murine asthma (28). A similar IL-4 independence of IL-5 production and function in helminth disease models has been reported (29, 30). Finally, the decreased production of IL-5 in the draining lymph node corresponded with a marked decrease in footpad eosinophilia, showing that anti-CD40 treatment had wide-reaching effects on both Th2 cytokine production and Th2-mediated cellular responses characteristic of helminth-induced tissue pathology.

Treatment with anti-CD40 mAb reciprocally induced 3- to 10-fold increases in IL-12 and IFN-{gamma} levels in vivo in this and other models of infection (13, 14, 15). We observed significant increases in circulating IL-12 that included both inactive free p40 and bioactive p70 forms. Whether there are distinct, additional cellular sources of local and systemic IFN-{gamma} production remains to be determined. Consistent with a CD4+ T cell source for production of this cytokine at the site of the Ag-specific immune response, IFN-{gamma} mRNA expression was enriched in CD4+ cells isolated from the LNC of anti-CD40-treated mice, whereas depletion of lymph node CD4+ cells reduced expression of IFN-{gamma} mRNA. Additionally, depletion of lymph node CD4+ cells decreased the frequency of IFN-{gamma}-secreting cells by 90%. These data are consistent with previous observations indicating Th1 cell differentiation was necessary for anti-CD40-induced cure of L. major infection in susceptible BALB/c mice (14). However, levels of spontaneous IFN-{gamma} production in our studies were high and minimally increased upon Ag stimulation. These findings therefore do not differentiate between cytokine synthesis by T cells induced by residual egg Ag in the harvested tissues or the additional presence of nonspecific bystander T cell and NK cell responses (31, 32, 33). Although CD4+ cellular immune responses were shown to contribute to the observed increase in Th1 cytokine activity after anti-CD40 treatment, further studies are needed to exclude an activated innate cellular immune response as an additional source for local or systemic IFN-{gamma} synthesis.

We initially hypothesized that the inhibition of developing Th2 responses by anti-CD40 mAb would be dependent on IL-12-elicited IFN-{gamma}. Consistent with this, C57BL/6 mice lacking either endogenous IFN-{gamma} or IL-12 were unable to down-regulate the egg-induced Th2 response following treatment with anti-CD40 mAb. However, anti-CD40 induced both local and systemic production of IFN-{gamma} in IL-12 p40-/- mice, yet did not suppress the S. mansoni egg-induced Th2 response. This observation is significant in two respects. First, the ability of CD40-induced responses to generate IL-12-independent IFN-{gamma} synthesis by CD4+ cells in vivo is in itself a novel finding. IL-12-independent Th1 cytokine responses have been observed previously in murine models of hepatitis coronavirus or Toxoplasma gondii infection, or in response to cardiac allograft (34, 35, 36). Additionally, McDyer et al. demonstrated that CD40 activation could enhance IFN-{gamma} production from PHA-stimulated human PBMCs cultured with {alpha}IL-12 (37). Our findings extend these observations to implicate CD40-activated responses in the synthesis of IL-12-independent IFN-{gamma} by CD4+ LNC. Possible pathways of action may include the induction of alternative IFN-{gamma}-inducing cytokines, such as IL-18, which may promote IFN-{gamma} production in the absence of IL-12 (38). Alternatively, IFN-{gamma} may be induced by enhanced IL-12-independent costimulatory interactions between T cells and CD40-activated APC (38).

Second, the induction of IFN-{gamma} synthesis by anti-CD40 treatment in the absence of IL-12 provides new insights into whether IFN-{gamma} alone is capable of mediating Th2-regulatory effects. The experimental inhibition of IL-12 activity in vivo is usually tightly associated with a concomitant down-regulation of IFN-{gamma} synthesis (39, 40). Consequently, immunomodulatory effects specifically attributable to IL-12 or IFN-{gamma} alone cannot be easily discerned. In contrast, treatment with anti-CD40 mAb dissociates the mutual regulatory interdependence of IL-12 and IFN-{gamma} and permits us to conclude that IFN-{gamma} alone is insufficient to down-regulate S. mansoni egg-induced Th2 responses. Further studies are needed to determine the molecular and cellular mechanisms responsible for anti-CD40-induced IFN-{gamma} synthesis in IL-12-deficient mice and to better define the joint requirement for IL-12 and IFN-{gamma} in the down-regulation of S. mansoni egg-induced immunity.

These findings show that CD40 activation in vivo inhibits the development and subsequent expression of IL-4-, IL-5-, and IL-13-producing cellular immune responses to a potent and well-characterized Th2-biasing stimulus. Our findings further suggest that the mechanism for Th2 inhibition is both IFN-{gamma} and IL-12 dependent. Finally, we demonstrate the capacity of CD40 activation to stimulate IFN-{gamma} synthesis in vivo in the absence of IL-12, although the development of Th2 cytokine production was not inhibited under these conditions. Because Th2 cytokine responses are a common pathogenic mechanism in a spectrum of clinical diseases, including atopy and helminth-induced tissue eosinophilia, these studies are significant in that they define a potent immunotherapy for inhibiting both Th2 cytokine production and Th2-dependent tissue responses. However, schistosome-infected mice treated with anti-CD40 do not demonstrate altered cytokine or Ab isotype production in ongoing preliminary studies. Further studies are needed to dissect the therapeutic effect of anti-CD40 in the chronic immune response of schistosome-infected mice. Our studies are also important in that they introduce a unique in vivo model of IL-12-independent IFN-{gamma} production that may provide new insights into alternative mechanisms for activation of Th1-type cellular immunity. We conclude that CD40 activation inhibits Th2 cytokine responses and promotes Th1 cellular immunity, including effects extending beyond the currently understood boundaries of the IL-12/IFN-{gamma} cascade.


   Acknowledgments
 
We thank Drs. Laurie Hall, Alan Levine, and Lloyd Culp for their many helpful reviews and suggestions in the writing of this manuscript.


   Footnotes
 
1 This work was supported by National Institute of Allergy and Infectious Diseases (NIAID) Grants RO1 AI35979 and K04 AI01229 (F.P.H.), NIAID Grants K04 AI01202 and P01AI 33061 (C.L.K.), and the Veterans Affairs Medical Research Service. Back

2 Address correspondence and reprint requests to Dr. Frederick Heinzel, Geographic Medicine, W-137, Case Western Reserve University School of Medicine, 2109 Adelbert Road, Cleveland, OH 44106-4983. E-mail address: Back

3 Abbreviations used in this paper: LNC, lymph node cell; HPRT, hypoxanthine phosphoribosyltransferase; MBP, major basic protein. Back

Received for publication July 14, 1999. Accepted for publication November 2, 1999.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Grzych, J. M., E. Pearce, A. Cheever, Z. A. Caulada, P. Caspar, S. Heiny, F. Lewis, A. Sher. 1991. Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. J. Immunol. 146:1322.[Abstract]
  2. Hoffmann, K. F., P. Caspar, A. W. Cheever, T. A. Wynn. 1998. IFN-{gamma}, IL-12, and TNF-{alpha} are required to maintain reduced liver pathology in mice vaccinated with Schistosoma mansoni eggs and IL-12. J. Immunol. 161:4201.[Abstract/Free Full Text]
  3. Wynn, T. A., D. Jankovic, S. Hieny, A. W. Cheever, A. Sher. 1995. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. J. Immunol. 154:4701.[Abstract]
  4. Wynn, T. A., A. W. Cheever, D. Jankovic, R. W. Poindexter, P. Caspar, F. A. Lewis, A. Sher. 1995. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376:594.[Medline]
  5. Vella, A. T., E. J. Pearce. 1992. CD4+ Th2 response induced by Schistosoma mansoni eggs develops rapidly, through an early, transient, Th0-like stage. J. Immunol. 148:2283.[Abstract]
  6. Oswald, I. P., P. Caspar, D. Jankovic, T. A. Wynn, E. J. Pearce, A. Sher. 1994. IL-12 inhibits Th2 cytokine responses induced by eggs of Schistosoma mansoni. J. Immunol. 153:1707.[Abstract]
  7. Subramanian, G., J. W. Kazura, E. Pearlman, X. Jia, I. Malhotra, C. L. King. 1997. B7-2 requirement for helminth-induced granuloma formation and CD4 type 2 T helper cell cytokine expression. J. Immunol. 158:5914.[Abstract]
  8. Trinchieri, G.. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251.[Medline]
  9. Stamenkovic, I., E. A. Clark, B. Seed. 1989. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 8:1403.[Medline]
  10. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747.[Abstract/Free Full Text]
  11. Koch, F., U. Stanzl, P. Jennewein, K. Janke, C. Heufler, E. Kampgen, N. Romani, G. Schuler. 1996. High level IL-12 production by murine dendritic cells: up-regulation via MHC class II and CD40 molecules and down-regulation by IL-4 and IL-10. J. Exp. Med. 184:741.[Abstract/Free Full Text]
  12. Stuber, E., W. Strober, M. Neurath. 1996. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med. 183:693.[Abstract/Free Full Text]
  13. Flamand, V., V. Donckier, F. X. Demoor, A. Le Moine, P. Matthys, M. L. Vanderhaeghen, Y. Tagawa, Y. Iwakura, A. Billiau, D. Abramowicz, M. Goldman. 1998. CD40 ligation prevents neonatal induction of transplantation tolerance. J. Immunol. 160:4666.[Abstract/Free Full Text]
  14. Ferlin, W. G., T. von der Weid, F. Cottrez, D. A. Ferrick, R. L. Coffman, M. C. Howard. 1998. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb. Eur. J. Immunol. 28:525.[Medline]
  15. Gurunathan, S., K. R. Irvine, C. Y. Wu, J. I. Cohen, E. Thomas, C. Prussin, N. P. Restifo, R. A. Seder. 1998. CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge. J. Immunol. 161:4563.[Abstract/Free Full Text]
  16. Heinzel, F. P., R. M. Rerko, A. M. Hujer. 1998. Underproduction of interleukin-12 in susceptible mice during progressive leishmaniasis is due to decreased CD40 activity. Cell. Immunol. 184:129.[Medline]
  17. French, R. R., H. T. Chan, A. L. Tutt, M. J. Glennie. 1999. CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help. Nat. Med. 5:548.[Medline]
  18. Maxwell, J. R., J. D. Campbell, C. H. Kim, A. T. Vella. 1999. CD40 activation boosts T cell immunity in vivo by enhancing T cell clonal expansion and delaying peripheral T cell deletion. J. Immunol. 162:2024.[Abstract/Free Full Text]
  19. Magram, J., J. Sfarra, S. Connaughton, D. Faherty, R. Warrier, D. Carvajal, C. Y. Wu, C. Stewart, U. Sarmiento, M. K. Gately. 1996. IL-12-deficient mice are defective but not devoid of type 1 cytokine responses. Ann. NY Acad. Sci. 795:60.[Medline]
  20. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-{gamma} genes. Science 259:1739.[Abstract/Free Full Text]
  21. Sabin, E. A., M. A. Kopf, E. J. Pearce. 1996. Schistosoma mansoni egg-induced early IL-4 production is dependent upon IL-5 and eosinophils. J. Exp. Med. 184:1871.[Abstract/Free Full Text]
  22. Boros, D. L., K. S. Warren. 1970. Delayed hypersensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs. J. Exp. Med. 132:488.[Abstract]
  23. Heinzel, F. P., R. M. Rerko, F. Ahmed, A. M. Hujer. 1996. IFN-{gamma}-independent production of IL-12 during murine endotoxemia. J. Immunol. 157:4521.[Abstract]
  24. Hall, L. R., R. K. Mehlotra, A. W. Higgins, M. A. Haxhiu, E. Pearlman. 1998. An essential role for interleukin-5 and eosinophils in helminth-induced airway hyperresponsiveness. Infect. Immun. 66:4425.[Abstract/Free Full Text]
  25. Pearlman, E., L. R. Hall, A. W. Higgins, D. S. Bardenstein, E. Diaconu, F. E. Hazlett, J. Albright, J. W. Kazura, J. H. Lass. 1998. The role of eosinophils and neutrophils in helminth-induced keratitis. Invest. Ophthalmol. Visual Sci. 39:1176.[Abstract/Free Full Text]
  26. Yamaguchi, Y., T. Suda, J. Suda, M. Eguchi, Y. Miura, N. Harada, A. Tominaga, K. Takatsu. 1988. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med. 167:43.[Abstract/Free Full Text]
  27. Chiaramonte, M. G., L. R. Schopf, T. Y. Neben, A. W. Cheever, D. D. Donaldson, T. A. Wynn. 1999. IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs. J. Immunol. 162:920.[Abstract/Free Full Text]
  28. Grunig, G., M. Warnock, A. E. Wakil, R. Venkayya, F. Brombacher, D. M. Rennick, D. Sheppard, M. Mohrs, D. D. Donaldson, R. M. Locksley, D. B. Corry. 1998. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282:2261.[Abstract/Free Full Text]
  29. Hogarth, P. J., M. J. Taylor, A. E. Bianco. 1998. IL-5-dependent immunity to microfilariae is independent of IL-4 in a mouse model of onchocerciasis. J. Immunol. 160:5436.[Abstract/Free Full Text]
  30. Pearce, E. J., A. Cheever, S. Leonard, M. Covalesky, R. Fernandez-Botran, G. Kohler, M. Kopf. 1996. Schistosoma mansoni in IL-4-deficient mice. Int. Immunol. 8:435.[Abstract/Free Full Text]
  31. Bennett, S. R., F. R. Carbone, F. Karamalis, R. A. Flavell, J. F. Miller, W. R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393:478.[Medline]
  32. Ridge, J. P., F. Di Rosa, P. Matzinger. 1998. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393:474.[Medline]
  33. Schoenberger, S. P., R. E. Toes, E. I. van der Voort, R. Offringa, C. J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480.[Medline]
  34. Piccotti, J. R., K. Li, S. Y. Chan, J. Ferrante, J. Magram, E. J. Eichwald, D. K. Bishop. 1998. Alloantigen-reactive Th1 development in IL-12-deficient mice. J. Immunol. 160:1132.[Abstract/Free Full Text]
  35. Scharton-Kersten, T., P. Caspar, A. Sher, E. Y. Denkers. 1996. Toxoplasma gondii: evidence for interleukin-12-dependent and -independent pathways of interferon-{gamma} production induced by an attenuated parasite strain. Exp. Parasitol. 84:102.[Medline]
  36. Schijns, V. E., B. L. Haagmans, C. M. Wierda, B. Kruithof, I. A. Heijnen, G. Alber, M. C. Horzinek. 1998. Mice lacking IL-12 develop polarized Th1 cells during viral infection. J. Immunol. 160:3958.[Abstract/Free Full Text]
  37. McDyer, J. F., T. J. Goletz, E. Thomas, C. H. June, R. A. Seder. 1998. CD40 ligand/CD40 stimulation regulates the production of IFN-{gamma} from human peripheral blood mononuclear cells in an IL-12- and/or CD28-dependent manner. J. Immunol. 160:1701.[Abstract/Free Full Text]
  38. Osaki, T., J. M. Peron, Q. Cai, H. Okamura, P. D. Robbins, M. Kurimoto, M. T. Lotze, H. Tahara. 1998. IFN-{gamma}-inducing factor/IL-18 administration mediates IFN-{gamma}- and IL-12-independent antitumor effects. J. Immunol. 160:1742.[Abstract/Free Full Text]
  39. Mattner, F., J. Magram, J. Ferrante, P. Launois, K. Di Padova, R. Behin, M. K. Gately, J. A. Louis, G. Alber. 1996. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 26:1553.[Medline]
  40. Heinzel, F. P., R. M. Rerko, F. Ahmed, E. Pearlman. 1995. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J. Immunol. 155:730.[Abstract]



This article has been cited by other articles:


Home page
 Infect. Immun.Home page
J. P. Hewitson, P. A. Hamblin, and A. P. Mountford
In the Absence of CD154, Administration of Interleukin-12 Restores Th1 Responses but Not Protective Immunity to Schistosoma mansoni
Infect. Immun., July 1, 2007; 75(7): 3539 - 3547.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. W. Hellings, A. Kasran, D. Bullens, L. Overbergh, C. Mathieu, H. Heremans, P. Matthys, L. Boon, M. Jorissen, and J. L. Ceuppens
IL-10- and IL-12-Independent Down-Regulation of Allergic Sensitization by Stimulation of CD40 Signaling
J. Immunol., October 15, 2006; 177(8): 5138 - 5144.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. A. Greene, J. L. DeVecchio, M. P. Gould, J. J. Auletta, and F. P. Heinzel
In vivo and In vitro Regulation of Type I IFN Synthesis by Synergistic Effects of CD40 and Type II IFN
J. Immunol., May 15, 2006; 176(10): 5995 - 6003.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. S. MacDonald, E. A. Patton, A. C. La Flamme, M. I. Araujo, C. R. Huxtable, B. Bauman, and E. J. Pearce
Impaired Th2 Development and Increased Mortality During Schistosoma mansoni Infection in the Absence of CD40/CD154 Interaction
J. Immunol., May 1, 2002; 168(9): 4643 - 4649.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. S. MacDonald, A. D. Straw, N. M. Dalton, and E. J. Pearce
Cutting Edge: Th2 Response Induction by Dendritic Cells: A Role for CD40
J. Immunol., January 15, 2002; 168(2): 537 - 540.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martin, D. L.
Right arrow Articles by Heinzel, F. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, D. L.
Right arrow Articles by Heinzel, F. P.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS